Efstathios Kastritis, MD, University of Athens School of Medicine, Athens, Greece, obtained his medical training from the University of Athens, School of Medicine. Dr Kastritis completed his residency in internal medicine at the Alexandra Hospital, University of Athens School of Medicine, Athens, Greece, where he is also an assistant professor at the department of clinical therapeutics. Since 2003, Dr Kastritis has also worked in the oncology and hematology department. Between 2008 and 2010, Dr Kastritis was a researcher at the University of Harvard, Dana-Farber Cancer Institute, division of Hematologic Neoplasia.
Speaking on plasma cell dycrasias
Dr Kastritis focuses on developing new diagnostic and therapeutic techniques for multiple myeloma, Waldenström’s macroglobulinemia and amyloidosis